Industry News

CMC Biologics is expanding its bioprocessing facility in Bothell, Wash., to house a 3,000-liter bioreactor train. Two 5,000-liter commercial-ready manufacturing lines will also be constructed. The project will support cGMP manufacturing of biopharmaceuticals.

Novartis broke ground in June of 2011 on a pharmaceutical manufacturing plant in St. Petersburg, Russia. Part of a five-year, $500 million investment, the facility will utilize advanced technologies to produce innovative therapeutics and generics. Completion is expected in 2014.

Trinity College Dublin opened the Trinity Biomedical Sciences Institute in June of 2011. The $189 million multidisciplinary facility houses the Institute of Immunology, the Cancer Drug Discovery Center of Excellence, the Bioengineering Center, and space for the Institute of Neuroscience. Providing academic, research, and commercial office space, the 11-story, 376,740-sf building will support preclinical medical training and research for the Schools of Medicine, Pharmacy and Pharmaceutical Science, Biochemistry and Immunology, Chemistry, and Engineering.

Emory University broke ground on the Health Sciences Research Building in June of 2011 in Atlanta. The 200,000-sf facility will support pediatric research and investigation into immunology, pharmaceutical discovery, and cancer. With four stories above ground and one below grade, the building will accommodate 65 lead researchers and their teams and will include a 175-seat auditorium. The $90 million facility was designed by ZGF (Zimmer Gunsul Frasca).

The Broad Institute is planning to construct a second facility in Cambridge, Mass. The 250,000-sf project will provide research and administrative space and will connect to the Institute's existing building on six stories to maximize collaboration. Construction will begin in early 2012 with completion expected in 2014.